James T. Borello
RPRX icon

James T. Borello’s Royalty Pharma RPRX Stock Holding History

James T. Borello’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.1K Buy
259
+11
+4% +$649 ﹤0.01% 495
2026
Q2 		$13.9K Buy
248
+8
+3% +$416 ﹤0.01% 504
2026
Q1 		$11.5K Buy
240
+1
+0.4% +$44 ﹤0.01% 527
2025
Q4 		$9.24K Buy
239
+2
+0.8% +$76 ﹤0.01% 436
2025
Q3 		$8.36K Buy
+237
New +$8.58K ﹤0.01% 337

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

James T. Borello's RPRX Position: Q3 2026 in Review

James T. Borello increased its Royalty Pharma (RPRX) stake by 4.4% in Q3 2026, buying an estimated $649 and bringing the position to 259 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

James T. Borello first reported a position in RPRX in Q3 2025 and has held it in 5 quarters since. 215 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • James T. Borello held 259 shares of Royalty Pharma worth $15.1K as of Q3 2026.
  • James T. Borello bought 11 Royalty Pharma shares in Q3 2026, an estimated $649.
  • Royalty Pharma made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #495 holding.
  • James T. Borello first reported a position in Royalty Pharma in Q3 2025 and has held it in 5 quarters since.
  • 215 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.